Wegovy is FDA-approved for chronic weight management and heart and liver risks reduction
The strongest associations were observed with semaglutide, which showed the most robust protective effect across all SUD categories, including an 85% reduction in AUD odds and an 87% reduction in OUD odds
But for drugs like tirzepatide, the challenge isnt convenienceits chemistry
Together, this science-driven delivery system and clinically studied actives provide a more targeted, efficient approach to body composition support
Notably, the recent release of transformative medicines such as Jaypirca (pirtobrutinib), an FDA-approved non-covalent BTK inhibitor for mantle cell lymphoma, and the promising Phase III study results of Jardiance, which showed significant kidney and cardiovascular benefits in adults with chronic kidney disease, have contributed to this growth